{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:32:13Z","timestamp":1785735133591,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.intimp.2008.08.016","type":"journal-article","created":{"date-parts":[[2008,9,14]],"date-time":"2008-09-14T05:53:08Z","timestamp":1221371588000},"page":"1787-1792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Characterization of YM-58483\/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo"],"prefix":"10.1016","volume":"8","author":[{"given":"Keiko","family":"Ohga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Takezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Arakida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2008.08.016_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceca.2004.06.010","article-title":"Calcium channels, transporters and exchangers in placenta: a review","volume":"37","author":"Belkacemi","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.intimp.2008.08.016_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1152\/physrev.00057.2003","article-title":"Store-operated calcium channels","volume":"85","author":"Parekh","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.intimp.2008.08.016_bib3","doi-asserted-by":"crossref","first-page":"20737","DOI":"10.1016\/S0021-9258(19)36843-7","article-title":"A GTP-dependent step in the activation mechanism of capacitative calcium influx","volume":"268","author":"Fasolato","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/physrev.1997.77.4.901","article-title":"Store depletion and calcium influx","volume":"77","author":"Parekh","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.intimp.2008.08.016_bib5","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.4049\/jimmunol.170.9.4441","article-title":"A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes","volume":"170","author":"Ishikawa","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib6","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1074\/jbc.M107755200","article-title":"Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes","volume":"277","author":"Ma","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib7","doi-asserted-by":"crossref","first-page":"C654","DOI":"10.1152\/ajpcell.1993.264.3.C654","article-title":"Inhibition of Ca2+ transport pathways in thymic lymphocytes by econazole, miconazole, and SKF 96365","volume":"264","author":"Mason","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.intimp.2008.08.016_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.immunol.19.1.497","article-title":"Calcium signaling mechanisms in T lymphocytes","volume":"19","author":"Lewis","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ncb1435","article-title":"Amplification of CRAC current by STIM1 and CRACM1 (Orai1).[see comment]","volume":"8","author":"Peinelt","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.intimp.2008.08.016_bib10","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1074\/jbc.C600126200","article-title":"Orai1 and STIM reconstitute store-operated calcium channel function","volume":"281","author":"Soboloff","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib11","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1127883","article-title":"CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry","volume":"312","author":"Vig","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.intimp.2008.08.016_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature05122","article-title":"Orai1 is an essential pore subunit of the CRAC channel","volume":"443","author":"Prakriya","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2008.08.016_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature05108","article-title":"Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai","volume":"443","author":"Yeromin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2008.08.016_bib14","first-page":"133","article-title":"Primary severe immunodeficiency due to impaired signal transduction in T cells","volume":"4","author":"Schlesier","year":"1993","journal-title":"Immunodeficiency"},{"key":"10.1016\/j.intimp.2008.08.016_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature04702","article-title":"A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function","volume":"441","author":"Feske","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2008.08.016_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20050687","article-title":"A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients","volume":"202","author":"Feske","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2008.08.016_bib17","doi-asserted-by":"crossref","first-page":"12427","DOI":"10.1074\/jbc.M309297200","article-title":"Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2","volume":"279","author":"Zitt","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib18","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1074\/jbc.M411797200","article-title":"A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2","volume":"280","author":"He","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib19","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1124\/mol.105.021154","article-title":"A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity","volume":"69","author":"Takezawa","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.intimp.2008.08.016_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0008-8749(03)00005-4","article-title":"TH1 and TH2 cytokine inhibition by 3,5-bis(trifluoromethyl)pyrazoles, a novel class of immunomodulators","volume":"220","author":"Chen","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib21","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1021\/jm990615a","article-title":"3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator","volume":"43","author":"Djuric","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib22","doi-asserted-by":"crossref","first-page":"48118","DOI":"10.1074\/jbc.M107919200","article-title":"Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds","volume":"276","author":"Trevillyan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pupt.2007.09.003","article-title":"The suppressive effects of YM-58483\/BTP-2, a store-operated Ca(2+) entry blocker, on inflammatory mediator release in vitro and airway responses in vivo","volume":"21","author":"Ohga","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.intimp.2008.08.016_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2007.01.012","article-title":"YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models","volume":"560","author":"Yoshino","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2008.08.016_bib25","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1016\/j.bmc.2006.03.024","article-title":"Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 1: synthesis and inhibitory activity of 5-(1-methyl-3-trifluoromethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamides","volume":"14","author":"Yonetoku","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.intimp.2008.08.016_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/clin.1996.0047","article-title":"Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro","volume":"79","author":"Furukawa","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.intimp.2008.08.016_bib27","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.4049\/jimmunol.155.5.2396","article-title":"Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells","volume":"155","author":"Rus","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.157.2.689","article-title":"IL-12 is a central mediator of acute graft-versus-host disease in mice","volume":"157","author":"Williamson","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-3083.2005.01595.x","article-title":"The pathophysiology of acute graft-versus-host disease","volume":"61","author":"Jaksch","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1600-6143.2003.00281.x","article-title":"The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models","volume":"4","author":"Kudlacz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.intimp.2008.08.016_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(01)00490-2","article-title":"Optimal analysis of composite cytokine responses during alloreactivity","volume":"260","author":"Jordan","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2008.08.016_bib32","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.4049\/jimmunol.161.6.2848","article-title":"Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production","volume":"161","author":"Shustov","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib33","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.4049\/jimmunol.162.8.4373","article-title":"Sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease","volume":"162","author":"Buhlmann","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib34","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.4049\/jimmunol.167.10.5741","article-title":"Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule\/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease","volume":"167","author":"Ogawa","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-5699(97)01186-9","article-title":"Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity","volume":"19","author":"Grabbe","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.intimp.2008.08.016_bib36","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1248\/bpb.19.1136","article-title":"Effect of mizoribine on effector T cell-mediated immune responses in mice","volume":"19","author":"Kamada","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.intimp.2008.08.016_bib37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0192-0561(94)90053-1","article-title":"Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses","volume":"16","author":"Reddy","year":"1994","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.intimp.2008.08.016_bib38","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.4049\/jimmunol.165.12.6783","article-title":"CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity","volume":"165","author":"Wang","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2008.08.016_bib39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-101-5-667","article-title":"Cyclosporine: a new immunosuppressive agent for organ transplantation","volume":"101","author":"Cohen","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.intimp.2008.08.016_bib40","first-page":"486","article-title":"Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis","volume":"33","author":"Karanikolas","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.intimp.2008.08.016_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/ajrccm.153.2.8564089","article-title":"Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma","volume":"153","author":"Lock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2008.08.016_bib42","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.intimp.2008.08.016_bib43","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ni966","article-title":"The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin","volume":"4","author":"Ryeom","year":"2003","journal-title":"Nat Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908002646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908002646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:04:28Z","timestamp":1761584668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576908002646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":43,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1567576908002646"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2008.08.016","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of YM-58483\/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2008.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}